AzTrials
AzTrials

ADHDCOGMOOD-TDAHNCT07812714

ADHD and Mental Effort

An observational study of ADHD, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record

Search all trials

Trial summary

ADHD is a common childhood disorder characterised by difficulties with attention and behaviour. Various cognitive characteristics are associated with ADHD, such as executive and motivational difficulties. Read more about this study

Who is it for?
Ages 7 to 18 years
Conditions the study is for
ADHD
How many people
80 participants
Where
1 siteFrance
Study dates
1 Oct 2026to 1 Oct 2028
Phase
Observational

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 7 to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Study population: Children aged between 7 years and 6 months and 18 years who have been diagnosed with ADHD and are being treated or hospitalised in the Child and Adolescent Psychiatry Department at Robert Debré Hospital, and who have not been diagnosed with ASD, an intellectual disability or a neurological condition.

Who may be able to join

  • Patients diagnosed with ADHD according to the DSM-5 criteria.
  • Receiving outpatient care or hospitalised within the Child and Adolescent
  • Psychiatry Department at Robert Debré Hospital.
  • Aged between 7 years and 6 months and under 18 years.
  • Who understand, speak and can read French.

Who cannot join

  • Presence of ASD or an intellectual disability.
  • Presence of a neurological comorbidity, regardless of type.
  • A person with parental authority who is under guardianship or conservatorship.
  • A patient under a medical emergency authorization (AME).
  • Objection expressed by at least one parent (regardless of the form: oral, written, or other).

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

France1 site
  • Hôpital Robert Debré

    Paris, 75019

    Eric ACQUAVIVA, MD, 0140034092 ext. +33, eric.acquaviva@aphp.fr

Other trials in France

About this study

Official title: Characterisation of Mental Effort in Children With ADHD

ADHD is a common childhood disorder characterised by difficulties with attention and behaviour. Various cognitive characteristics are associated with ADHD, such as executive and motivational difficulties.

Beyond these characteristics, our hypothesis is that children with ADHD may have specific strategies for allocating mental effort, influenced by motivational and metacognitive factors Our study assesses these dimensions using a behavioural task and a computational model in children with ADHD, both with and without treatment.

It aims to identify individual cognitive profiles correlated with clinical characteristics. A better understanding of the cognitive mechanisms involved in ADHD would enable the development of personalised management of the disorder.

Read the detailed description

Children hospitalized or receiving care for ADHD at the Child and Adolescent Psychiatry Department of Robert Debré Hospital will be invited to participate in the study following verification of inclusion criteria and confirmation of no parental objection.

Each participant will complete two experimental sessions, spaced 1 to 12 weeks apart, reflecting the standard follow-up and assessment schedule for children with ADHD.

If treatment is initiated during the follow-up period, at least one of the sessions will take place no more than 12 hours after a dose of medication.

Each session will include a computerized cognitive task lasting approximately one hour-assessing memory and motivation-as well as the collection of standardized clinical data (ADHD-RS diagnostic questionnaires for ADHD and DSM-5-based assessments for mental disorders).

The study does not alter standard care; it is conducted within the framework of routine clinical follow-up, involving no interruption of treatment and offering no financial benefit to participants.

Conditions
ADHD
Keywords
ADHD, psychiatry, pediatry, mental effort
Medical subject headings
Attention Deficit Disorder with Hyperactivity

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. group-level correlation between individual cognitive parameters (motivational and metacognitive) and individual clinical sub-scores for inattention and hyperactivity/impulsivity on the ADHDRS scale.

    To evaluate whether individual cognitive profiles derived from computational modeling explain a portion of the variability in individual clinical profiles in ADHD (inattention, hyperactivity/impulsivity).

    Measured: 2 years

Secondary outcomes (2)
  1. Mean within-participant difference between ADHD treatment conditions (ON vs OFF) in the computational-model-derived motivational parameter from the Memory and Stroop tasks

    To assess, at the group level, the within-participant difference between sessions with and without ADHD treatment in the individually fitted motivational parameter of the computational model. This parameter, expressed in task point-equivalents, quantifies the motivational value associated with the allocation of mental effort during the neurocognitive tasks. For each participant and session, the parameter is estimated by fitting the computational model to the participant's observed effort-allocation behavior during the Memory and Stroop tasks. The outcome reported is the group-level mean of the individual ON-versus-OFF differences in the fitted motivational parameter, expressed in task point-equivalents

    Measured: 2 years

  2. Mean within-participant difference between ADHD treatment conditions (ON vs OFF) in the computational-model-derived metacognitive parameter from the Memory and Stroop tasks

    To assess, at the group level, the within-participant difference between sessions with and without ADHD treatment in the individually fitted metacognitive parameter of the computational model. This parameter, expressed in percent correct per second, quantifies the participant's subjective evaluation of her efficacy at making progress in the tasks, which contributes to the allocation of mental effort. For each participant and session, the parameter is estimated by fitting the computational model to the participant's observed effort-allocation behavior during the Memory and Stroop tasks. The outcome reported is the group-level mean of the individual ON-versus-OFF differences in the fitted metacognitive parameter, expressed in percent correct per second.

    Measured: 2 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Sep 2026
  2. Study start1 Oct 2026 (estimated)
  3. Primary completion1 Oct 2028 (estimated)
  4. Study completion1 Oct 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07812714
Sponsor's protocol ID
APHP260157
Other IDs
2026-A01213-48
Acronym
COGMOOD-TDAH
Status last verified
Sep 2026
First submitted
28 Aug 2026
Last updated
10 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in